CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.38
Delayed Data
As of 10:03am ET
 +0.0258 / +1.91%
Today’s Change
1.07
Today|||52-Week Range
2.09
+3.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.0023.7K23.7K
 
 
 
Cost of Goods Sold0.000.007.5K--
 
 
Depreciation And Amortization12.6K13.5K15.5K--
 
 
 
 
 
Operating ExpensesGross Income-12.6K-13.5K794.00--
 
 
 
 
General Expenses1.6M1.8M1.6M1.8M
 
 
 
 
 
Research And Development724.5K697.0K784.0K865.0K
 
 
 
 
 
Total Operating Expenses1.6M1.8M1.6M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.6M-1.8M-1.6M-1.8M
 
 
 
 
 
Extraordinary Credit0.000.0018.3K--
 
 
Extraordinary Charge0.00-19.7M0.00--
 
 
Interest Expense On Debt0.003.5K24.5K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-21.5M-1.6M--
 
 
 
 
Net Income-1.6M-21.5M-1.6M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.0M27.8M32.4M32.4M
 
 
 
 
 
Shares To Calculate EPS Diluted27.0M27.8M32.4M32.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.77-$0.05-$0.06
 
 
 
 
 
EPS Diluted-$0.06-$0.77-$0.05-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account